Statistics & reproducibility
breast cancer
BREAST CANCER
This is a randomized controlled trial. The eligible participants were randomized into two groups: (a) those using 12 weeks of TICAA with ACS website on breast cancer and (b) those using 12 weeks of the ACS website alone. The Investigators were not blinded to allocation during experiments and outcome assessment. The data were collected at three time points (T0, T1, & T2).In the sample size calculation, a sample size of 99 participants in each group (total An intent-to-treat approach was used; the participants were analyzed in their original randomized conditions regardless of the usages of TICAA or follow-ups missed. Missing values were not substituted. Again, 69 women were excluded during the data analysis process because they were not eligible because of several reasons (e.g., missing information on primary outcomes at the baseline). Because the outcome variables showed non-normal distributions, generalized estimating equations were used to examine group differences in continuous outcomes at each time point, after adjusting for the baseline outcome and covariates that demonstrated differences. There existed no significant differences between the two groups except access to health care (